摘要:
It is to provide a method for treating skin aging, or a method for treating skin scar that can exert a sufficient effect. A composition for treating skin aging comprising bFGF for treating aging of the skin that is administered intradermally or subcutaneously, or a composition for treating skin scar comprising bFGF for treating scar of skin that is administered intradermally or subcutaneously is utilized. Preferred examples of aging of skin include skin wrinkle, pigmented spot, sagging skin, rough skin, skin thinning, decrease of skin viscoelasticity, etc., and preferred examples of scar include keloid, hypertrophic scar, scar contracture, etc.
摘要:
An organ regeneration device adapted to be used by placing it into a defective portion of an organ to regenerate the organ is provided. The organ regeneration device has a base body having a shape corresponding to a shape of the defective portion of the organ. The organ regeneration device also has particles carried on the base body, wherein the particles are composed of a different material from that of the base body. The organ regeneration device also has a growth-related substance contained in the organ regeneration device for growth and differentiation of cells around the defective portion. The growth-related substance contains an angiogenesis factor. Further, the growth-related substance contains nucleic acid containing a base sequence coding for amino-acid sequence of a growth factor different from the angiogenesis factor. Furthermore, the nucleic acid is introduced into a host cell.
摘要:
A method for forming an implant having a desired shape includes the steps of (a) forming a layer of ingredient powder having a predetermined thickness composed of an ingredient powder, and (b) applying an reactant liquid to the layer in accordance with the desired shape of the implant, portions of the ingredient powder reacting with the reactant liquid being hardened. The above steps are repeated to stack a plurality of the layers having hardened portions, respectively, to form a three-dimensional implant formed by a stack of the hardened portions of the layers of the ingredient powder. The ingredient powder is a powder including at least one of a-tricalcium phosphate and tetracalcium phosphate, and a Ca/P ratio of the powder is within a range of 1.40 through 2.0.
摘要:
Powders treated with silicones represented by the following formula (1): R1aR2bR3cSiO(4−a−b−c)/2 (1) wherein R1, R2, R3 a, b and c are as defined herein, are suitable for use in cosmetic materials.
摘要:
A colored plastic lens includes a plastic substrate having first and second surfaces, a resin film with a pigment dispersed therein formed on one of the first and second surfaces of the plastic substrate, and a coating film, preferably a hard coat film, formed on the resin film and the surface of the lens on which the resin film is not formed. A method of forming the colored plastic lens includes providing a plastic substrate having first and second sides, dispersing a pigment in a resin vehicle, coating the pigment dispersed in the resin vehicle on one of the first and second sides of the plastic substrate to thereby form a resin film, and forming a coating film, preferably a hard coat film, on the resin film and the surface of the lens on which the resin film is not formed.
摘要:
A hydrolyzate resulting from co-hydrolysis of a perfluoroalkyl group-containing organic silicon compound and a hydrolyzable group-containing methylpolysiloxane compound in a hydrophilic solvent and water constitutes a water repellent agent which is effective for imparting water repellency and facilitating falling of water droplets and thus imparting excellent water repellency and stain-proofness to a surface of an article treated therewith.
摘要:
Organosilicon compounds of a novel class are disclosed including .alpha.,.omega.-bis(alkoxy silyl)-substituted alkane compounds represented by the general formula(RO).sub.m (CH.sub.3).sub.3-m Si--CH.sub.2).sub.n Si(CH.sub.3).sub.3-m (OR).sub.m,in which R is a monovalent hydrocarbon group having 1 to 4 carbon atoms, e.g., methyl and ethyl, the subscript n is a positive integer in the range from 10 to 18 and the subscript m is 1, 2 or 3. The compound is useful as an additive in various kinds of synthetic resin-based compositions for the purpose of improving the properties such as flexibility, weatherability, cold resistance and mechanical strengths.
摘要:
The present invention provides a method for testing mesothelioma comprising a step of determining a concentration of a human periostin protein in at least one type of sample of blood or pleural fluid of a subject. In the step of determining the concentration of human periostin protein, an antibody directed against human periostin protein may be used. The present invention further provides a kit for diagnosing mesothelioma, said kit comprising an antibody directed against human periostin protein. In the kit for diagnosing mesothelioma, the antibody directed against a human periostin protein may be an antibody that binds to a polypeptide consisting of an amino acid sequence set out in SE ID NO: 2.
摘要翻译:本发明提供了一种用于测试间皮瘤的方法,包括测定受试者的至少一种类型的血液或胸膜液样品中人骨膜素蛋白浓度的步骤。 在确定人骨膜素蛋白浓度的步骤中,可以使用针对人骨膜素蛋白的抗体。 本发明还提供了用于诊断间皮瘤的试剂盒,所述试剂盒包含针对人骨膜素蛋白的抗体。 在用于诊断间皮瘤的试剂盒中,针对人骨膜素蛋白的抗体可以是与由SE ID NO:2中列出的氨基酸序列组成的多肽结合的抗体。
摘要:
The present invention provides novel antibodies that recognize the extracellular domain of a human CLCP1 antigen; nucleic acids encoding the antibodies; vectors carrying the nucleic acids in an expressible manner; transformed cells containing the vectors; methods for producing the antibodies; diagnostic methods for cancer or prognosis of cancer, immunohistological or immunocytological assay methods, and kits for determining the expression level of CLCP1 in cells or tissues, all of which use the antibodies; pharmaceutical compositions comprising the antibodies; agents for treating or preventing CLCP1-expressing cancer; agents for inhibiting growth, migration, invasion, or metastasis of CLCP1-expressing cancer cells; immunostaining agents for staining CLCP1-expressing cancer cells; and agents for treating or preventing CLCP1-expressing tumor. The present invention also provides methods of screening for candidate substances that inhibit cancer cell growth, invasion, migration, or metastasis, or candidate substances having cytotoxicity against cancer cells.
摘要:
It is to provide an agent for preventing and treating skin aging, or an agent for treating skin scar that can exert a sufficient effect. An agent for preventing and treating skin aging comprising bFGF for treating aging of the skin that is administered intradermally or subcutaneously, or an agent for treating skin scar comprising bFGF for treating scar of skin that is administered intradermally or subcutaneously is utilized. Preferred examples of aging of skin include skin wrinkle, pigmented spot, sagging skin, rough skin, skin thinning, decrease of skin viscoelasticity, etc., and preferred examples of scar include keloid, hypertrophic scar, scar contracture, etc.